Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas.
Perry M, Delarche A, Ribes D, Vergez F, Guilbeau-Frugier C, Laurent C, Huart A, Tavitian S, El Hachem H, Oberic L, Chauveau D, Michallet AS, Ysebaert L, Faguer S. Perry M, et al. Among authors: tavitian s. Am J Hematol. 2014 Oct;89(10):969-73. doi: 10.1002/ajh.23798. Epub 2014 Jul 30. Am J Hematol. 2014. PMID: 25043930 Free article. Clinical Trial.
Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies.
Bertoli S, Sterin A, Tavitian S, Oberic L, Ysebaert L, Bouabdallah R, Vergez F, Sarry A, Bérard E, Huguet F, Laurent G, Prébet T, Vey N, Récher C. Bertoli S, et al. Among authors: tavitian s. Oncotarget. 2016 Dec 27;7(52):85937-85947. doi: 10.18632/oncotarget.13262. Oncotarget. 2016. PMID: 27852053 Free PMC article.
Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response.
Guenounou S, Borel C, Bérard E, Yon E, Fort M, Mengelle C, Bertoli S, Sarry A, Tavitian S, Huguet F, Attal M, Récher C, Huynh A. Guenounou S, et al. Among authors: tavitian s. Medicine (Baltimore). 2016 Nov;95(48):e5356. doi: 10.1097/MD.0000000000005356. Medicine (Baltimore). 2016. PMID: 27902595 Free PMC article.
Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.
Ribes D, Hachem HEL, Oberic L, Vergez F, Delas A, Belliere J, Protin C, Kamar N, Ferrandiz I, Tavitian S, Laurent C, Huart A, Chauveau D, Ysebaert L, Faguer S. Ribes D, et al. Among authors: tavitian s. Am J Hematol. 2018 Mar;93(3):356-362. doi: 10.1002/ajh.24984. Epub 2017 Dec 6. Am J Hematol. 2018. PMID: 29168251 Free article.
Improved outcome for AML patients over the years 2000-2014.
Bertoli S, Tavitian S, Huynh A, Borel C, Guenounou S, Luquet I, Delabesse E, Sarry A, Laurent G, Attal M, Huguet F, Bérard E, Récher C. Bertoli S, et al. Among authors: tavitian s. Blood Cancer J. 2017 Nov 29;7(12):635. doi: 10.1038/s41408-017-0011-1. Blood Cancer J. 2017. PMID: 29184070 Free PMC article.
Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies.
Bertoli S, Tavitian S, Berard E, Gadaud N, Luquet I, Huynh A, Sarry A, Huguet F, Récher C. Bertoli S, et al. Among authors: tavitian s. Leuk Lymphoma. 2019 Jan;60(1):238-241. doi: 10.1080/10428194.2018.1464156. Epub 2018 Jun 12. Leuk Lymphoma. 2019. PMID: 29893611 No abstract available.
82 results